A preventive therapy of the central nervous system complications in acute leukemias. Preliminary report
- PMID: 279080
A preventive therapy of the central nervous system complications in acute leukemias. Preliminary report
Abstract
A new therapeutic schedule for preventive therapy of the central nervous system (CNS) complications by intrathecal (i.t.) injections of methotrexate (MTX) was applied in two groups of 6 and respectively 13 adults with acute lymphoblastic or non-lymphoblastic leukemias. Instead of starting this treatment only in the remission stage, i.t. MTX was given from the very beginning of cytostatic therapy. In most of the patients this drug proved to be effective in preventing CNS involvement. In some cases, however, it was not well, tolerated owing probably to a neurotoxic effect. This suggested continuation of the study with Ara-C.
Similar articles
-
The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.Haematologica. 1997 Sep-Oct;82(5):577-80. Haematologica. 1997. PMID: 9407724 Clinical Trial.
-
Antimetaboliths in the prophylaxis and treatment of central nervous system leukemia.Cancer Treat Rep. 1977 Jul;61(4):661-6. Cancer Treat Rep. 1977. PMID: 267507
-
Effect of the intermittent prophylactic treatment of the central nervous system in adults with acute leukemia.Biomed Pharmacother. 1987;41(9-10):462-7. Biomed Pharmacother. 1987. PMID: 3482982
-
[Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].Bull Cancer. 2008 Jul-Aug;95(7):707-15. doi: 10.1684/bdc.2008.0645. Bull Cancer. 2008. PMID: 18755650 Review. French.
-
[New principles of treatment in acute leukemia].Ugeskr Laeger. 1970 Apr 30;132(18):821-30. Ugeskr Laeger. 1970. PMID: 4912575 Review. Danish. No abstract available.